Area of research
Surgery · Biomaterials
Research interest
Research focused on Cancer research and Hepatocellular carcinoma, with related work in FOXP3, MAPK/ERK pathway, Vimentin. Notable publications include 'CD4<sup>+</sup> CD25<sup>+</sup> regulatory T cells promote hepatocellular carcinoma invasion via TGF-&beta;1-induced epithelial&ndash;mesenchymal...', 'Polydatin executes anticancer effects against glioblastoma multiforme by inhibiting the EGFR-AKT/ERK1/2/STAT3-SOX2/Snail signaling pathway', and 'Ultrasound‑targeted microbubble destruction‑mediated Foxp3 knockdown may suppress the tumor growth of HCC mice by relieving immunosuppressive Tregs function'.
Correction to: PFP@PLGA/Cu12Sb4S13‑mediated PTT ablates hepatocellular carcinoma by inhibiting the RAS/MAPK/MT‑CO1 signaling pathway
PFP@PLGA/Cu12Sb4S13-mediated PTT ablates hepatocellular carcinoma by inhibiting the RAS/MAPK/MT-CO1 signaling pathway
Polydatin executes anticancer effects against glioblastoma multiforme by inhibiting the EGFR-AKT/ERK1/2/STAT3-SOX2/Snail signaling pathway
CD4<sup>+</sup> CD25<sup>+</sup> regulatory T cells promote hepatocellular carcinoma invasion via TGF-&beta;1-induced epithelial&ndash;mesenchymal transition
Ultrasound‑targeted microbubble destruction‑mediated Foxp3 knockdown may suppress the tumor growth of HCC mice by relieving immunosuppressive Tregs function
TNRC9 rs12443621 and FGFR2 rs2981582 polymorphisms and breast cancer risk
Combined effect of ultrasound/SonoVue microbubble on CD4+CD25+ regulatory T cells viability and optimized parameters for its transfection